Dr. Jeffrey G. Mulhern, MD

Dr. Mulhern practices at Kidney Care and Transplant Services of New England in West Springfield, Massachusetts.

Dr. Mulhern's NPI, 1063402105, was assigned on October 27, 2005. Dr. Mulhern holds Massachusetts license 55789.

Dr. Mulhern's primary practice is Kidney Care and Transplant Services of New England, at 134 Capital Dr, West Springfield, MA 01089 in Hampden County. The practice phone is (413) 733-0010.

Dr. Mulhern's primary practice is Kidney Care and Transplant Services of New England in West Springfield, Massachusetts. Dr. Mulhern is also affiliated with Baystate Medical Center. The medical group on file is Kidney Care and Transplant Services of New England. Dmand AI also links Dr. Mulhern to 4 more hospitals, 3 group practices and clinics, 2 dialysis centers and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mulhern practices, 10 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Mulhern's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dmand AI has Dr. Mulhern's licenses on file in 2 states: Massachusetts and Connecticut.

CMS data shows 2,796 Medicare services from Dr. Mulhern across 9 procedure codes in 2024, for 423 Medicare patients. Medicare paid $65,654 for them.

CMS counts 423 Medicare patients who saw Dr. Mulhern in 2024. The largest group is 75 to 84, with 158 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 39% are also on Medicaid. Their average risk score is 2.86, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mulhern's median patient age at 70, with 50% women.

In 2024, Dr. Mulhern wrote 3,013 Medicare Part D claims for 341 patients. 81% of them were for generic drugs. CMS names the drug for 2,412 of them, across 66 drugs with 11 or more claims each, at $525,851 in total drug cost. In 2023, CMS named 1,988 claims across 50 drugs.

Dr. Mulhern accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 5 papers to Dr. Mulhern, published from 2019 to 2025. The most frequent topics are Renal Dialysis. Dr. Mulhern's most frequent co-authors are Graham Edwin Abra, MD, Michael S. Anger, MD and Michael A. Aragon, MD.

Dmand AI links Dr. Mulhern to 1 clinical trial. Conditions studied include Polycystic Kidney, Autosomal Dominant and Polycystic Kidney Diseases.

CMS Open Payments shows 7 general payments to Dr. Mulhern from 5 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 49% of the total. Fresenius USA Marketing, Inc. paid the most, $532.